Bourgeon Capital Management LLC raised its stake in Henry Schein, Inc. (NASDAQ:HSIC) by 4.5% during the second quarter, Holdings Channel reports. The fund owned 16,910 shares of the company’s stock after buying an additional 725 shares during the period. Henry Schein accounts for approximately 1.9% of Bourgeon Capital Management LLC’s portfolio, making the stock its 24th largest position. Bourgeon Capital Management LLC’s holdings in Henry Schein were worth $3,095,000 as of its most recent filing with the SEC.

A number of other institutional investors have also bought and sold shares of HSIC. Wedbush Securities Inc. increased its position in Henry Schein by 3.8% in the second quarter. Wedbush Securities Inc. now owns 1,600 shares of the company’s stock valued at $293,000 after buying an additional 58 shares during the last quarter. Rhumbline Advisers increased its position in Henry Schein by 1.3% in the second quarter. Rhumbline Advisers now owns 159,392 shares of the company’s stock valued at $29,172,000 after buying an additional 2,065 shares during the last quarter. DekaBank Deutsche Girozentrale increased its position in Henry Schein by 5.9% in the second quarter. DekaBank Deutsche Girozentrale now owns 30,881 shares of the company’s stock valued at $5,707,000 after buying an additional 1,707 shares during the last quarter. First Trust Advisors LP increased its position in Henry Schein by 45.9% in the second quarter. First Trust Advisors LP now owns 124,236 shares of the company’s stock valued at $22,738,000 after buying an additional 39,105 shares during the last quarter. Finally, Schwab Charles Investment Management Inc. increased its position in Henry Schein by 3.9% in the second quarter. Schwab Charles Investment Management Inc. now owns 274,419 shares of the company’s stock valued at $50,225,000 after buying an additional 10,181 shares during the last quarter. 90.87% of the stock is currently owned by hedge funds and other institutional investors.

Shares of Henry Schein, Inc. (HSIC) opened at 170.58 on Friday. The firm’s 50-day moving average is $181.54 and its 200-day moving average is $175.12. Henry Schein, Inc. has a 12-month low of $146.23 and a 12-month high of $186.99. The company has a market capitalization of $13.49 billion, a PE ratio of 24.93 and a beta of 1.09.

Henry Schein (NASDAQ:HSIC) last announced its earnings results on Tuesday, August 8th. The company reported $1.75 EPS for the quarter, topping the consensus estimate of $1.73 by $0.02. The business had revenue of $3.06 billion during the quarter, compared to the consensus estimate of $3.05 billion. Henry Schein had a net margin of 4.59% and a return on equity of 19.91%. Henry Schein’s revenue was up 6.4% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.64 EPS. On average, equities research analysts anticipate that Henry Schein, Inc. will post $7.28 EPS for the current fiscal year.

WARNING: This report was first published by Daily Political and is owned by of Daily Political. If you are reading this report on another site, it was illegally stolen and reposted in violation of United States & international copyright & trademark laws. The legal version of this report can be viewed at https://www.dailypolitical.com/2017/08/12/bourgeon-capital-management-llc-has-3-10-million-stake-in-henry-schein-inc-hsic.html.

Several research firms have commented on HSIC. Zacks Investment Research downgraded shares of Henry Schein from a “buy” rating to a “hold” rating in a research report on Wednesday. Northcoast Research raised shares of Henry Schein from a “neutral” rating to a “buy” rating and set a $218.00 target price on the stock in a research report on Monday, August 7th. BidaskClub downgraded shares of Henry Schein from a “hold” rating to a “sell” rating in a research report on Wednesday, August 2nd. Jefferies Group LLC reissued a “hold” rating and set a $177.00 target price on shares of Henry Schein in a research report on Friday, July 21st. Finally, Credit Suisse Group reissued a “hold” rating and set a $160.00 target price on shares of Henry Schein in a research report on Thursday, July 13th. One analyst has rated the stock with a sell rating, ten have given a hold rating and seven have issued a buy rating to the company. The stock presently has a consensus rating of “Hold” and an average price target of $185.56.

About Henry Schein

Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.